ABCB1 and Alzheimer disease: Moreover, the complex pathway involving Wnt, beta-catenin and GSK-3 seems to be involved in the disruption of the BBB occurring in AD, via the altered expression of multidrug efflux transporters and P-glycoprotein by the ependymal cells [130-132].